Pharmacy customers' knowledge of side effects of purchased medicines in Mexico

Tropical Medicine and International Health

Volumn 14, Issue 1, 2009, Pages 93-100

  Wirtz, Veronika J ^a   Taxis, Katja ^b   Dreser, Anahi ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Clients; Drugs; Knowledge; Mexico; Pharmacy; Side effects

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPROTOZOAL AGENT; ANTIULCER AGENT; CORTICOSTEROID DERIVATIVE; HERBACEOUS AGENT; MUCOLYTIC AGENT; NON PRESCRIPTION DRUG; PARACETAMOL; VITAMIN;

DIABETES; DRUG; NUMERICAL MODEL; REGRESSION ANALYSIS;

ADULT; ARTICLE; CHRONIC PAIN; CONSUMER HEALTH INFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INFORMATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; KNOWLEDGE; MALE; MEXICO; PHARMACY; PRESCRIPTION; PURCHASING; SEMI STRUCTURED INTERVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; CROSS-SECTIONAL STUDIES; DRUG INFORMATION SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEXICO; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHARMACEUTICAL PREPARATIONS; PHARMACIES; YOUNG ADULT;

EID: 58449109125     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02186.x     Document Type: Article

References (24)

1. Altagracia MM, Kravzov JJ, Moreno SR, Ríos CC Vázquez ME (2003) Self-medication in rural and urban communities in the state of Guerrero Mexico. Revista Mexicana de Ciencias Farmaceuticas 34, 27 35.
2. Angeles-Chimal P, Medina-Flores ML Molina-Rodriguez JF (1992) Self-medication in the urban population of Cuernavaca, Morelos. Salud Pública de México 34, 554 561.
3. Becker D, Garcia SG Ellertson C (2004) Do Mexico City workers screen women for health risks when they sell oral contraceptive pills over-the-counter? Contraception 69, 295 299.
4. Berry DC, Michas IC, Gillie T Forster M (1997) What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study. Psychology and Health 12, 467 480.
5. Berry D, Bradlow A Bersellini E (2004) Perception of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology 43, 901 905.
6. Cham E, Hall L, Ernst AA Weiss SJ (2002) Awareness and use of over-the-counter pain medications: a survey of emergency department patients. Southern Medical Journal 95, 529 535.
7. Cullen G, Kelly E Murray FE (2006) Patients' knowledge of adverse reactions to current medications. British Journal of Clinical Pharmacology 62, 232 236.
8. Gilbertson RJ, Harris E, Pandey SK, Kelly P Myers W (1996) Paracetamol use, availability, and knowledge of toxicity among British and American adolescents. Archives of Disease in Childhood 75, 194 195.
9. Hughes L, Whittlesea C Luscombe D (2002) Patients' knowledge and perceptions of the side-effects of OTC medication. Journal of Clinical Pharmacy and Therapeutics 27, 243 248.
10. Kroeger A, Oocha H, Arana B et al. (2001) Inadequate drug advice in the pharmacies of Guatemala and Mexico: the scale of the problem and explanatory factors. Annals of Tropical Medicine and Parasitology 95, 605 616.
11. Leyva-Flores R (2002) Conditions of the consumption of medicines in community drugstores from Mexico 1996. PhD Thesis, Department of Sociology and Organizational Research, Universidad de Barcelona, Barcelona.
12. Mahmud T, Comer M, Roberts K, Berry H Scott DL (1995) Clinical implications of patients' knowledge. Clinical Rheumatology 14, 627 630.
13. Mehta D (2006) British Medical Formulary (BNF). 52nd Edn. Pharmaceutical Press, London.
14. Raynor DK, Blenkinsopp A, Knapp P et al. (2007) A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment 11, iii, 1 160.
15. Rivas JF (2001) Promotion and marketing of anti-diarrheal drugs in the Mexican market. Hitos de Ciencias Económico Administrativas 17, 7 14.
16. SSA-COFEPRIS (2005) Towards a Comprehensive Pharmaceutical Policy for Mexico. [Hacia una política farmacéutica integral para México]. SSA, México, D.F.
17. Sweetman S (2006) Martindale: The Complete Drug Reference. 35th Edn. Pharmaceutical Press, London.
18. Turner AN, Ellertson C, Thomas S García S (2003) Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results form a random sample of Mexico City pharmacy attendants. Sexually Transmitted Infections 79, 224 228.
19. US National Library of Medicine (2007) Medline Plus Dictionary. http://www.nlm.nih.gov/medlineplus/mplusdictionary.html (accessed 30 December, 2007).
20. Vázquez-Moreno E, Moreno-Santamaría R, Altagracia- Martínez M, Kravzov-Jinich J Ríos-Castañeda C (2004) Self-medication in the Mexican State of Veracruz. Journal of Pharmaceutical Finance, Economics and Policy 13, 45 63.
21. Vicencio Acevedo D, Alfaro Valle A Martínez Toledo JL (1995) [Characteristics of drug acquisition in Morelia (Michoacán), Mexico.]. Boletín de la Oficina Sanitaria Panamericana 119, 236 242.
22. Wirtz V, Cribb A Barber N (2006) Patient-doctor decision-making about treatment within the consultation - a critical analysis of models. Social Science & Medicine 62, 116 124.
23. Wirtz V, Reich M, Leyva R Dreser A (2008). Medicines in Mexico 1990-2004: a systematic review on access and use. Salud Pública de México 50 (in press).
24. Ziegler DK, Mosier MC, Buenaver M Okuyemi K (2001) How much information about adverse effects of medication do patients want from physicians? Archive of Internal Medicine 161, 706 713.